Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Smoking Abstinence
NCT00578552Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Oct 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin in Tobacco Use Disorder (TUD), sponsored by Mayo Clinic. Started Oct 2007; status: completed.
02
Drugs
gabapentin
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00578552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00578552.